Showing results (61-70 of 344) with videos related to

Sort By:
Pageof 35
BMC Cancer|November 18, 2020
Bortezomib administration is a risk factor associated with the development of tumor lysis syndrome in male patients with multiple myeloma: a retrospective studyMasahiro Kondo, Yuji Hotta, Karen Yamauchi, et al.
Pathology International|March 26, 2018
Improved clonality detection in Hodgkin lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH and IGK rearrangements: A paraffin-embedded tissue studyShusen Han, Ayako Masaki, Yuma Sakamoto, et al.
International Journal of Hematology|May 29, 2024
Isatuximab with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: post-marketing surveillance in JapanNami Tagami, Michihiro Uchiyama, Kenshi Suzuki, et al.
International Journal of Hematology|August 18, 2005
Detection of API2-MALT1 fusion transcripts in cytologic specimens of patients with pulmonary mucosa-associated lymphoid tissue lymphomaHiroshi Inagaki, Chunmei Li, Mitsukuni Okabe, et al.
The Journal of Craniofacial Surgery|August 1, 2006
Therapeutic choice for craniofacial venous malformationsSadanori Akita, Kozo Akino, Katsumi Tanaka, et al.
No Shinkei Geka. Neurological Surgery|June 15, 2010
[Clinical application of the Colorado-microdissection needle in neurosurgery]Shiro Baba, Takayuki Matsuo, Ryujiro Ushijima, et al.
The Journal of Craniofacial Surgery|November 23, 2006
Cranioplasty with auto-purified bone flap after infectionHiroki Yano, Katsumi Tanaka, Takayuki Matsuo, et al.
Plastic and Reconstructive Surgery|January 13, 2006
Cranial vault distraction: its illusionary effect and limitationHiroki Yano, Katsumi Tanaka, Osamu Sueyoshi, et al.
Drug Metabolism and Pharmacokinetics|February 3, 2020
Clinical study designs and patient selection methods based on genomic biomarkers: Points-to-consider documentsMasahiro Tohkin, Yoshiro Saito, Satomi Yagi, et al.
International Journal of Hematology|November 17, 2016
Elotuzumab with lenalidomide and dexamethasone for Japanese patients with relapsed/refractory multiple myeloma: phase 1 studyShinsuke Iida, Hirokazu Nagai, Gen Kinoshita, et al.
Pageof 35